Incretins, a new strategy to treat type 2 diabetes

被引：0
|
作者：
Tan, Kimny [1 ]
Pillon, Francois [2 ]
机构：
[1] Fac Pharm, Dijon 21, France
[2] Pharm, Dijon 21, France
来源：
ACTUALITES PHARMACEUTIQUES | 2009年 / 48卷 / 481期
关键词：
D O I：
10.1016/S0515-3700(09)70012-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [41] Advanced study: new therapeutic strategy in type 2 diabetes?
    Nee, David
    PRESSE MEDICALE, 2007, 36 (11): : 1592 - 1592
  • [42] CARDIOVASCULAR EFFECTS OF INCRETINS IN PATIENTS WITH TYPE 1 DIABETES
    Arutyunova, M.
    Glazunova, A.
    Martynov, S.
    Klephortova, I.
    Ilyin, A.
    Manchenko, O.
    Ulianova, I.
    Shamkhalova, M.
    Shestakova, M.
    ATHEROSCLEROSIS, 2016, 252 : E141 - E141
  • [43] Liver X receptors: new drug targets to treat Type 2 diabetes?
    Steffensen, Knut R.
    Gustafsson, Jan-Ake
    FUTURE LIPIDOLOGY, 2006, 1 (02): : 181 - 189
  • [44] Molecular targets for new drug discovery to treat type 2 diabetes and obesity
    Bastarrachea, Raul A.
    Montero, Julio C.
    Saavedra-Gajardo, Victor
    Cerda-Flores, Ricardo
    Machado-Dominguez, Anselmo
    Comuzzie, Anthony G.
    REVISTA MEDICA DE CHILE, 2008, 136 (01) : 107 - 117
  • [45] Cold therapy—a potential new approach to treat type 2 diabetes mellitus?
    Nature Reviews Endocrinology, 2015, 11 (9) : 506 - 506
  • [46] Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review
    Pulla, Venkat Koushik
    Battu, Madhu Babu
    Alvala, Mallika
    Sriram, Dharmarajan
    Yogeeswari, Perumal
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (08) : 819 - 832
  • [47] Targeting the CNS to treat type 2 diabetes
    Sandoval, Darleen A.
    Obici, Silvana
    Seeley, Randy J.
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) : 386 - 398
  • [48] Targeting the CNS to treat type 2 diabetes
    Darleen A. Sandoval
    Silvana Obici
    Randy J. Seeley
    Nature Reviews Drug Discovery, 2009, 8 : 386 - 398
  • [49] Incretins, incretinomimetics and DPP-IV inhibitors: glucose homeostasis and type 2 diabetes
    Virally, Marie
    Kevorkian, Jean-Philippe
    Guillausseau, Pierre-Jean
    SANG THROMBOSE VAISSEAUX, 2008, 20 (09): : 453 - 461
  • [50] Possible Mechanisms and Molecular Signaling of Incretins against the Development of Type 2 Diabetes Mellitus
    Salami, Raziyeh
    Salami, Marziyeh
    Mafi, Alireza
    Aarabi, Mohammad-Hossein
    Vakili, Omid
    Asemi, Zatollah
    CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (04) : 448 - 464
12345